These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31414564)

  • 1. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
    Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R
    Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
    Schroeder L; Wichmann G; Willner M; Michel A; Wiesenfarth M; Flechtenmacher C; Gradistanac T; Pawlita M; Dietz A; Waterboer T; Holzinger D
    Int J Cancer; 2018 Apr; 142(7):1361-1368. PubMed ID: 29159804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.
    Schroeder L; Boscolo-Rizzo P; Dal Cin E; Romeo S; Baboci L; Dyckhoff G; Hess J; Lucena-Porcel C; Byl A; Becker N; Alemany L; Castellsagué X; Quer M; León X; Wiesenfarth M; Pawlita M; Holzinger D
    Eur J Cancer; 2017 Mar; 74():73-81. PubMed ID: 28335889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
    Scholes AG; Liloglou T; Snijders PJ; Hart CA; Jones AS; Woolgar JA; Vaughan ED; Walboomers JM; Field JK
    Int J Cancer; 1997 May; 71(5):796-9. PubMed ID: 9180148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
    Huang Q; Li F; Ji M; Lin L; Hu C
    BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
    Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
    Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
    N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
    Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
    Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
    Friedland P; Thomas A; Naran A; Amanuel B; Grieu-Iacopetta F; Carrello A; Harnett G; Meyer C; Phillips M
    ANZ J Surg; 2012 May; 82(5):362-6. PubMed ID: 22507644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection.
    Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM
    Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.
    Mitra S; Banerjee S; Misra C; Singh RK; Roy A; Sengupta A; Panda CK; Roychoudhury S
    J Clin Pathol; 2007 Sep; 60(9):1040-7. PubMed ID: 17079356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus.
    Motz K; Qualliotine JR; Rettig E; Richmon JD; Eisele DW; Fakhry C
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):223-8. PubMed ID: 26769661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.
    Ragin CC; Taioli E; Weissfeld JL; White JS; Rossie KM; Modugno F; Gollin SM
    Br J Cancer; 2006 Nov; 95(10):1432-8. PubMed ID: 17003776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
    Ganly I; Soutar DS; Brown R; Kaye SB
    Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.